In [Table 1](#pone-0093346-t001){ref-type="table"}, values for Sinus rhythm and Pace maker rhythm in the Cardiac rhythm section are incorrect. The correct version of [Table 1](#pone-0093346-t001){ref-type="table"} can be viewed here.

10.1371/journal.pone.0073184.t001

###### Demographic characteristics of the study patients.
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                                       Total study patients   eGFR \<60 mL/min/m^2^   eGFR ≥60 mL/min/m^2^  
  ----------------------------------- ---------------------- ----------------------- ---------------------- ---------
  Clinical characteristics                                                                                  
   Age                                      65.4±13.0              68.4 ±10.9              58.3 ±14.9        \<0.001
   Sex (women/men)                            27/73                  10 /60                  17 /13          \<0.001
   Body mass index, kg/m^2^                  23.1±3.1               23.2 ±3.0              23.0 ±3.2          0.740
   Systolic blood pressure, mmHg           126.1 ±19.7             126.5 ±19.6            125.1 ±20.1         0.744
   Diastolic blood pressure, mmHg           71.6 ±12.4             70.9 ±12.0              73.3 ±13.2         0.364
   Pulse rate, bpm                          72.3 ±13.7             72.6 ±14.9              71.4 ±10.5         0.695
  Past History                                                                                              
   previous PCI                             44(44.0 )               33(47.1 )              11(36.7 )          0.333
   previous CABG                             7(7.0 )                 4(5.7 )                3(10.0 )          0.441
  Cardiovascular disease                                                                                    
   Ischemic heart disease, n (%)            59 (59.0 )             43 (61.4 )              16 (53.3 )         0.451
   Cardiomyopathy, n (%)                    10 (10.0 )              7 (10.0 )              3 (10.0 )          1.000
   NYHA class III/IV, n (%)                 12 (12.0 )              5 (7.1 )               7 (23.3 )          0.022
   Aortic aneurysm, n (%)                    6 (6.0 )               5 (7.1 )                1 (3.3 )          0.462
   Arrythmia, n (%)                         22 (22.0 )             12 (17.1 )              10 (33.3 )         0.073
   Peripheral artery disease, n (%)          8 (8.0 )               7 (10.0 )              1 ( 3.3 )          0.260
   Valvular heart disease, n (%)            8 ( 8.0 )              7 ( 10.0 )              1 ( 3.3 )          0.260
  Cardiac rhythm                                                                                            
   Sinus rhythm, n (%)                     78 ( 78.0 )             56 ( 80.0 )            22 ( 73.3 )         0.687
   Atrial fibrillation, n (%)              15 ( 15.0 )             10 ( 14.3 )             5 ( 16.7 )       
   Pace maker rhythm, n (%)                 7 ( 7.0 )               4 ( 5.7 )              3 ( 10.0 )       
  Smoking status                                                                                            
   Never, n (%)                            33 ( 33.0 )             24 ( 34.3 )             9 ( 30.0 )         0.658
   Former, n (%)                           50 ( 50.0 )             33 ( 47.1 )            17 ( 56.7 )       
   Current, n (%)                          17 ( 17.0 )             13 ( 18.6 )             4 ( 13.3 )       
  Medication                                                                                                
   ACE inhibitors/ARB, n (%)               51 ( 51.0 )             41 ( 58.6 )            10 ( 33.3 )         0.021
   Beta blockers, n (%)                    38 ( 38.0 )             32 ( 45.7 )             6 ( 20.0 )         0.015
   Calcium channel blockers, n (%)         44 ( 44.0 )             35 ( 50.0 )             9 ( 30.0 )         0.065
   Aldosterone antagonist, n (%)           13 ( 13.0 )             11 ( 15.7 )             2 ( 6.7 )          0.218
  Diuretics                                                                                                 
   Loop, n (%)                             18 ( 18.0 )             15 ( 21.4 )             3 ( 10.0 )         0.173
   Thiazide, n (%)                          5 ( 5.0 )               4 ( 5.7 )              1 ( 3.3 )          0.617
  Antidiabetic drugs                                                                                        
   Sulfonylurea, n (%)                     10 ( 10.0 )             7 ( 10.0 )              3 ( 10.0 )         1.000
   DPP4 inhibitors, n (%)                   9 ( 9.0 )               6 ( 8.6 )              3 ( 10.0 )         0.819
   Insulin, n (%)                           4 ( 4.0 )               2 ( 2.9 )              2 ( 6.7 )          0.373
   Others, n (%)                            8 ( 8.0 )               4 ( 5.7 )              4 ( 13.3 )         0.198
  Lipid lowering drugs                                                                                      
   Statin, n (%)                           52 ( 52.0 )             39 ( 55.7 )            13 ( 43.3 )         0.256
   Fibrate, n (%)                           1 ( 1.0 )               0 ( 0.0 )              1 ( 3.3 )          0.125
   Others, n (%)                            7 ( 7.0 )               6 ( 8.6 )              1 ( 3.3 )          0.347

PCI, percutaneous coronary intervention; coronary artery bypass graft; ACE, angiotensin converting enzyme; ARB, angiotensin II receptor blocker; DPP4, di-peptidyl peptidase-4. P values are meant to the comparison between eGFR ≥60 mL/min/m^2^ and \<60 mL/min/m^2^ groups.

The corrected versions of [Tables 3](#pone-0093346-t002){ref-type="table"} and [4](#pone-0093346-t003){ref-type="table"} are also incorrect. Additional significant figures were added during the correction of these tables. The publisher apologizes for these errors. The correct versions of [Tables 3](#pone-0093346-t002){ref-type="table"} and [4](#pone-0093346-t003){ref-type="table"} can be viewed here.

10.1371/journal.pone.0073184.t003

###### Spearman\'s correlation coefficients between FGF23 and various variables.
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                                FGF23                                    
  ---------------------------- ------- ------- ------- --------- ------- -------
  Age, year                     -0.03   0.751   0.05     0.706    -0.44   0.014
  Sex, (male  = 1)              0.11    0.293   -0.01    0.960    0.20    0.294
  Body mass index               -0.20   0.049   -0.26    0.032    -0.13   0.497
  Systolic blood pressure       -0.17   0.083   -0.14    0.247    -0.26   0.174
  Diastolic blood pressure      -0.17   0.083   -0.16    0.176    -0.14   0.460
  Pulse rate                    0.02    0.866   0.18     0.127    -0.58   0.001
  White blood cell count        -0.04   0.684   -0.14    0.260    0.18    0.348
  Hemoglobin                    -0.24   0.014   -0.41   \<0.001   0.18    0.350
  Platelet count                0.00    0.968   0.04     0.740    -0.02   0.922
  Total protein                 0.13    0.191   0.17     0.151    0.04    0.848
  Albumin                       -0.06   0.534   -0.16    0.198    0.19    0.313
  Total cholesterol             -0.01   0.907   -0.04    0.736    0.11    0.579
  LDL cholesterol               -0.02   0.875   -0.07    0.577    0.12    0.518
  HDL cholesterol               0.06    0.548   0.14     0.261    -0.05   0.803
  Triglycerides                 -0.05   0.587   -0.15    0.215    0.19    0.317
  Blood urea nitrogen           0.19    0.061   0.24     0.044    -0.01   0.949
  Creatinine                    0.20    0.051   0.11     0.386    0.47    0.009
  eGFR                          -0.18   0.079   -0.12    0.318    -0.29   0.124
  Alanine transaminase          -0.13   0.188   -0.25    0.040    0.31    0.091
  Aspartate transaminase        -0.14   0.180   -0.23    0.059    0.16    0.405
  B-type natriuretic peptide    0.20    0.050   0.16     0.179    0.23    0.215
  C-reactive protein            0.03    0.797   0.08     0.501    -0.09   0.650
  Corrected calcium             -0.02   0.874   -0.04    0.715    0.03    0.873
  Inorganic phosphate           0.19    0.056   0.23     0.054    0.18    0.341
  Intact parathyroid hormone    0.07    0.503   0.00     0.991    0.23    0.226
  25(OH) Vitamin D, pg/mL       -0.03   0.759   -0.07    0.577    -0.05   0.812
  1,25(OH)~2~ Vitamin D         0.01    0.917   0.03     0.785    -0.06   0.753

10.1371/journal.pone.0073184.t004

###### Spearman's correlation coefficients between α-Klotho and various variables.
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                                α-Klotho                                  
  ---------------------------- ---------- ------- ------- ------- ------- -------
  Age, year                       0.04     0.717   0.07    0.563   0.00    0.992
  Sex, (male  = 1)                0.14     0.174   0.27    0.023   0.00    0.984
  Body mass index                 0.08     0.430   0.12    0.335   0.03    0.855
  Systolic blood pressure         0.16     0.111   0.16    0.199   0.23    0.216
  Diastolic blood pressure        0.18     0.066   0.17    0.166   0.27    0.147
  Pulse rate                      0.13     0.215   0.04    0.740   0.41    0.023
  White blood cell count          0.01     0.927   0.02    0.856   -0.09   0.649
  Hemoglobin                      0.20     0.050   0.24    0.046   0.07    0.705
  Platelet count                 -0.13     0.207   -0.09   0.439   -0.28   0.131
  Total protein                  -0.06     0.576   -0.11   0.373   0.06    0.740
  Albumin                         0.19     0.065   0.18    0.125   0.16    0.399
  Total cholesterol               0.04     0.672   0.05    0.681   -0.03   0.879
  LDL cholesterol                 0.02     0.822   0.08    0.515   -0.18   0.348
  HDL cholesterol                 0.10     0.320   0.05    0.669   0.19    0.316
  Triglycerides                  -0.05     0.646   0.01    0.927   -0.16   0.400
  Blood urea nitrogen            -0.25     0.014   -0.33   0.005   -0.08   0.672
  Creatinine                     -0.15     0.141   -0.21   0.084   -0.16   0.410
  eGFR                            0.15     0.143   0.20    0.102   0.24    0.197
  Alanine transaminase            0.15     0.128   0.22    0.072   -0.07   0.712
  Aspartate transaminase          0.23     0.021   0.29    0.014   0.13    0.496
  B-type natriuretic peptide     -0.20     0.047   -0.24   0.043   -0.07   0.706
  C-reactive protein             -0.16     0.123   -0.08   0.526   -0.39   0.034
  Corrected calcium               0.09     0.390   0.05    0.657   0.13    0.486
  Inorganic phosphate            -0.17     0.091   -0.23   0.059   -0.10   0.586
  Intact parathyroid hormone     -0.08     0.428   0.03    0.794   -0.30   0.103
  25(OH) Vitamin D, pg/mL         0.16     0.114   0.10    0.392   0.34    0.062
  1,25(OH)~2~ Vitamin D           0.17     0.083   0.17    0.165   0.10    0.582
